Corbus Pharmaceuticals Holdings, Inc. (CRBP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
500 River Ridge Drive
Norwood, MA 02062
United States of America (the)
Phone
617 963 0100
Website
Sector
Healthcare
Industry
Biotechnology
Employees
36
First IPO Date
October 27, 2014
| Name | Title | Pay | Year Born |
| Yuval Cohen | Chief Executive Officer & Director | 1.04M | 1975 |
| Sean F. Moran | Chief Financial Officer | 695,745 | 1958 |
| Dominic Smethurst | Chief Medical Officer | 720,988 | 1975 |
| Ian Hodgson | Chief Operating Officer | 0 | 1973 |
| G. Scott Goeken | General Counsel & Corporate Secretary | 0 | N/A |
| Nishant C. Saxena | Chief Business Officer | 0 | N/A |
| Christina Bertsch | Vice President of Human Resources | 0 | N/A |
Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. The company was founded in April 2009 and is headquartered in Norwood, MA.